AI could revolutionise glaucoma detection. Here’s 6 things everyone should know - Age and family history are significant risk ...
Many people are unaware that they have this common eye condition.
Health experts in Plateau and Kaduna States have raised an alarm over the growing burden of glaucoma, urging Nigerians to undergo ...
A new study published in the Lancet Primary Care has found that an AI tool correctly identified 78 per cent of people with the common eye condition, compared to 75 per cent detected by medical ...
Glaucoma is one of the leading causes of irreversible blindness worldwide, yet many people do not notice its symptoms early. Experts say regular eye check-ups are the only way to detect the condition ...
The Tshwane district issued the highest number of spectacles to adults in Gauteng as the country and the world mark World Glaucoma Week (March 8–14).
A woman suffered "avoidable" sight loss after waiting two years for NHS cataract surgery in Wales. The woman endured 11 cancelled apppointments and failures in the management of her care during the ...
Company launched TONMYA, approved by the FDA as a treatment for fibromyalgia, in November 2025 In post hoc analysis of the pivotal RESILIENT study, TONMYA produced rapid pain relief as early as Day 2 ...
TONMYA™ (cyclobenzaprine HCl sublingual tablets) launched November 17, 2025, for the treatment of fibromyalgia; through February 27, 2026, more than 1,500 healthcare providers have prescribed TONMYA ...
TONMYA (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults, was commercially launched in November 2025 Treatment with TONMYA provided statistically significant pain ...